🔬Deep Research
HRTX — Heron Therapeutics Inc · catalysts, narrative & risks
Heron Therapeutics Inc (HRTX) — Research Summary as of August 14, 2026
Company Overview
Heron Therapeutics is a commercial-stage biotechnology company focused on acute care therapeutics. Its product portfolio includes ZYNRELEF (a dual-acting local anesthetic), APONVIE, CINVANTI, and SUSTOL [8].
Key Recent Catalysts (Last ~1–3 Months)
AI-assisted research from the K3vl4r desk — not personalized investment advice. More research →